0001144204-19-033813.txt : 20190703 0001144204-19-033813.hdr.sgml : 20190703 20190703170041 ACCESSION NUMBER: 0001144204-19-033813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20190703 DATE AS OF CHANGE: 20190703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bright Lisa CENTRAL INDEX KEY: 0001635111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 19942485 MAIL ADDRESS: STREET 1: 450 W. 15TH STREET, SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tv524732_form4.xml FORM 4 X0306 4 2019-07-01 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001635111 Bright Lisa C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 0 1 0 0 President, International Common Stock 2019-07-01 4 F 0 530 79.17 D 20452 D Common Stock 2019-07-03 4 S 0 595 78.66 D 19857 D Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock awards previously granted to the reporting person. This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person. /s/ Mark Pruzanski, as attorney-in-fact 2019-07-03